Disclosed herein are cannabinoid receptor ligands of formula (I)
wherein L
1
, A
1
, R
1g
, z, R
2
, R
3
, and R
4
are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.